Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5382)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2020 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou PC, Sun LQ, Shao L, Yi LZ, Li N, Fan XG. Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2020; 26(31): 4607-4623 [PMID: 32884220 DOI: 10.3748/wjg.v26.i31.4607] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i31/4607.htm |
| Number | Citing Articles |
| 1 |
Huiqin Jiang, Wenjing Yang, Anli Jin, Hao Wang, Tong Li, Jingrong Xian, Wei Chen, Ling Ding, Beili Wang, Wei Guo. Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current
State and Future Perspectives. Current Chinese Science 2023; 3(6): 420 doi: 10.2174/2210298103666230410105139
|
| 2 |
Wenjun Pu, Xi Wang, Xiaoni Zhong, Dong Zhao, Zhipeng Zeng, Wanxia Cai, Yafang Zhong, Jianrong Huang, Donge Tang, Yong Dai. Dysregulation of lipid metabolism in the pseudolobule promotes region-specific autophagy in hepatitis B liver cirrhosis. Hepatology Communications 2023; 7(8) doi: 10.1097/HC9.0000000000000187
|
| 3 |
Lin-Lin Cao, Yi Han, Lin Pei, Zhi-Hong Yue, Bo-Yu Liu, Jing-Wen Cui, Mei Jia, Hui Wang. A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2022; 12(7): 610 doi: 10.3390/metabo12070610
|
| 4 |
Xingyun Wu, Zihao Wang, Li Luo, Dan Shu, Kui Wang. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine. Frontiers in Medical Technology 2023; 4 doi: 10.3389/fmedt.2022.1065506
|
| 5 |
Aihua Zhang, Hui Sun, Xijun Wang. Mass Spectrometry‐Based Metabolomics in Clinical and Herbal Medicines. 2021; : 113 doi: 10.1002/9783527835751.ch8
|
| 6 |
Nguyen Hoang Anh, Nguyen Phuoc Long, Young Jin Min, Yujin Ki, Sun Jo Kim, Cheol Woon Jung, Seongoh Park, Sung Won Kwon, Seul Ji Lee. Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis. Metabolites 2023; 13(11): 1112 doi: 10.3390/metabo13111112
|
| 7 |
Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang, Li-hong Jiang. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Annals of Medicine 2023; 55(1): 42 doi: 10.1080/07853890.2022.2153163
|
| 8 |
Noora Kano, Elizabeth J. Want, Mark J. W. McPhail. Metabolomics in Advanced Liver Disease. Current Treatment Options in Gastroenterology 2021; 19(2): 380 doi: 10.1007/s11938-021-00347-w
|
| 9 |
Mingxin Cui, Fengzhi Qu, Libing Wang, Xiaogang Liu, Jingkun Yu, Zhaoyuan Tang, Daming Cheng. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomarkers 2022; 33(3): 389 doi: 10.3233/CBM-210154
|
| 10 |
Lin-Lin Cao, Yi Han, Yuanxiao Wang, Lin Pei, Zhihong Yue, Li Qin, Boyu Liu, Jingwen Cui, Mei Jia, Hui Wang. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.816748
|
| 11 |
Wenqian Wang, Shanshan Zhen, Yu Ping, Liping Wang, Yi Zhang. Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1331215
|